Abstract
We report a case of cavitary pulmonary disease caused by Mycobacterium shimoidei in 67-year-old female with history of asthma. Even though susceptibility testing was not available, choice of treatment regimen (streptomycin, rifampicin, ethambutol, and clarithromycin), based on a few cases with favorable outcome reported in the literature, resulted with an excellent clinical, microbiological, and radiological response. This is the first report of pulmonary disease caused by M. shimoidei, but also the first ever isolation of M. shimoidei in Croatia.
This is a preview of subscription content, log in via an institution to check access.
References
Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW (2013) Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 68:256–262
Auergan G, Ramarson F, Génin C, Vincent Lévy-Frébault V (1997) A case of Mycobacterium shimoidei lung infection in Madagascar. Bull Soc Pathol Exot 90:75–77
Biswas N, Brown T, Dakin J (2011) The first case of Mycobacterium shimoidei infection in the UK. ERS Int Congress 2011:P2716
Chomyc SA, Pearson JH, Helbecque D (1991) Mycobacterium shimoidei–Alberta. Can Dis Wkly Rep 17:85–86
Furrer H, Bodmer T, von Overbeck J (1994) Disseminated nontuberculous mycobacterial infections in AIDS patients. Schweiz Med Wochenschr 124:89–96
Galizzi N, Tortoli E, Gori A, Morini F, Lapadula G (2013) A case of mild pulmonary disease due to Mycobacterium shimoidei with a favorable outcome. J Clin Microbiol 51:3467–3468
Goudge RJ, Mayall BC, Leslie DE, Holmes PW, Robinson SA (1998) An Australian isolate of Mycobacterium shimoidei. Pathology 30:399–401
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F (2007) ATS Mycobacterial disease Subcommitte, American Thoracic Society, Infection Diseases Society of America. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Heller R, Jaulhac B, Charles P, De Briel D, Vincent V, Bohner C, Piemont Y, Monteil H (1996) Identification of Mycobacterium shimoidei in a tuberculosis-like cavity by 16S ribosomal DNA direct sequencing. Eur J Clin Microbiol Infect Dis 15:172–175
Hojo M, Iikura M, Hirano S, Sugiyama H, Kobayashi N, Kudo K (2012) Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Respirology 17:185–190
Jankovic M, Samarzija M, Sabol I, Jakopovic M, Katalinic Jankovic V, Zmak L, Ticac B, Marusic A, Obrovac M, van Ingen J (2013) Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis 17:836–841
Jankovic M, Sabol I, Zmak L, Jankovic Katalinic V, Jakopovic M, Obrovac M, Ticac B, Bulat LK, Grle SP, Marekovic I, Samarzija M, van Ingen J (2016) Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology. Int J Tuberc Lung Dis 20:934–940
Jurcev-Savicevic A, Mulic R, Ban B, Kozul K, Bacun-Ivcek L, Valic J, Popijac-Cesar G, Marinovic-Dunatov S, Gotovac M, Simunovic A (2013) Risk factors for pulmonary tuberculosis in Croatia: a matched case-control study. BMC Public Health 13:991
Kanaji N, Kushida Y, Bandoh S, Ishii T, Haba R, Tadokoro A, Watanabe N, Takahama T, Kita N, Dobashi H, Matsunaga T (2013) Membranous glomerulonephritis associated with Mycobacterium shimoidei pulmonary infection. Am J Case Rep 14:543–547
Koukila-Kähkölä P, Paulin L, Brander E, Jantzen E, Eho-Remes M, Katila ML (2000) Characterisation of a new isolate of Mycobacterium shimoidei from Finland. J Med Microbiol 49:937–940
Mayall B, Gurtler V, Irving L, Marzec A, Leslie D (1999) Identification of Mycobacterium shimoidei by molecular techniques: case report and summary of the literature. Int J Tuberc Lung Dis 3:169–173
Miller MA, Eymard D, Thibert L (1991) Mycobacterium shimoidei: first reported isolate in Canada. Can Dis Wkly Rep 17:11–12
Rüsch-Gerdes S, Wandelt-Freerksen E, Schröder KH (1985) Occurrence of Mycobacterium shimoidei in West Germany. Zentralbl Bakteriol Mikrobiol Hyg A 259:146–150
Saito H, Zayasu K, Shigeto E, Iwamoto T, Nakanaga K, Kodama A, Ishii N (2007) Two cases of lung infection due to Mycobacterium shimoidei, with special reference to bacteriological investigation. Kansenshogaku Zasshi 81:12–19
Sundman K, Chryssanthou E, Petrini B (2000) Mycobacterium shimoidei, an easily misdiagnosed non-tuberculous pulmonary mycobacterium. Scand J Infect Dis 32:450–451
Takayama S, Tominaga S, Tsukada Y, Ohkochi M, Inase N (2006) A case of pulmonary Mycobacterium shimoidei infection. Kekkaku 81:537–541
Tortoli E, Simonetti MT (1991) Isolation of Mycobacterium shimoidei from a patient with cavitary pulmonary disease. J Clin Microbiol 29:1754–1756
Tsukamura M (1982) Mycobacterium shimoidei sp. nov., nom. rev., a lung pathogen. Int J Syst Bacteriol 32:67–69
Tsukamura M, Shinoide H, Shaefer WB (1975) A possible new pathogen of group III mycobacteria. J Gen Microbiol 88:377–380
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent including pictures for the publication of this case report was taken from the patient involved in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Popovic, V., Arar, D., Popovic, D.R. et al. Mycobacterium shimoidei—cavitary pulmonary disease with favorable outcome. Folia Microbiol 63, 249–252 (2018). https://doi.org/10.1007/s12223-017-0548-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-017-0548-1